Top UK endocrinologist joins the team
Leading endocrinologist Professor Neil Hanley has been
appointed by the Trust's Research & Innovation (R&I)
Professor of Endocrinology Prof Hanley and his research group
have been at the forefront of studies in human endocrine
development and stem cell biology. They were the second group in
the world to report on cells consistent with human embryonic germ
cells. These studies on the early human germ cell lineage provide
information that translates clinically into improved understanding
of germ cell tumours (GCT). The group's stem cell research is also
focused on the long-term goal of generating pancreatic beta cells
from embryonic stem (ES) cells, either as potential therapy or as
background knowledge that facilitates advances in endogenous beta
cell regeneration in patients.
Collaboration with industry is also a key component of Prof
Hanley's work. As part of a government and pharmaceutical industry
consortium, he is studying the human fetal liver and pancreas using
patented novel 3-D air-liquid interface cultures. The aim is
ultimately to improve drug toxicology screening in the
pharmaceutical industry. Prof Phil Baker, clinical head of the
R&I Division commented:
"Our ability to attract clinicians and researchers who lead
their field is a testament to Manchester's excellent reputation for
patient-driven research, "
" Appointing Neil is major coup for our growing team, and he
brings a tremendous wealth of both research and clinical
Neil Hanley studied pharmacology, medicine and surgery at the
University of Edinburgh from 1990 to 1996. He subsequently gained a
PhD in molecular genetics from the University of Newcastle in 2001.
From 1998 to 2000 he was Visiting Fellow to the laboratory of Dr.
Keith Parker, Division of Endocrinology & Metabolism,
University of Texas Southwestern Medical Center at Dallas, Texas.
Prof Hanley then took up senior appointments at the University of
Southampton from 2000, and became Honorary Consultant
Endocrinologist at Southampton University Hospitals NHS Trust in